Pavmed Inc (PAVM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 28,427 | 27,285 | -33,426 | -18,512 | -79,263 |
| Depreciation Amortization | 1,198 | 1,129 | 891 | 586 | 2,932 |
| Accounts receivable | 43 | 45 | -158 | -6 | -44 |
| Accounts payable and accrued liabilities | -59 | -249 | -553 | -301 | -918 |
| Other Working Capital | 512 | -563 | -44 | 378 | 1,591 |
| Other Operating Activity | -63,675 | -61,295 | 8,525 | 4,746 | 23,666 |
| Operating Cash Flow | $-33,554 | $-33,648 | $-24,765 | $-13,109 | $-52,036 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -55 | -51 | -45 | -42 | -242 |
| Purchase Sale Intangibles | 350 | 350 | N/A | N/A | 1,000 |
| Other Investing Activity | -16,129 | -16,129 | 0 | 0 | 1,000 |
| Investing Cash Flow | $-16,184 | $-16,180 | $-45 | $-42 | $758 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | -531 | N/A | 9,921 |
| Debt Repayment | N/A | -531 | N/A | -322 | N/A |
| Common Stock Issued | 2,017 | 1,687 | 1,403 | 1,205 | 2,627 |
| Other Financing Activity | 29,267 | 29,798 | 29,798 | 18,165 | 18,625 |
| Financing Cash Flow | $31,284 | $30,954 | $30,670 | $19,048 | $31,173 |
| Beginning Cash Position | 19,639 | 19,639 | 19,639 | 19,639 | 39,744 |
| End Cash Position | 1,185 | 765 | 25,499 | 25,536 | 19,639 |
| Net Cash Flow | $-18,454 | $-18,874 | $5,860 | $5,897 | $-20,105 |
| Free Cash Flow | |||||
| Operating Cash Flow | -33,554 | -33,648 | -24,765 | -13,109 | -52,036 |
| Capital Expenditure | -55 | -51 | -45 | -42 | -242 |
| Free Cash Flow | -33,609 | -33,699 | -24,810 | -13,151 | -52,278 |